"10.1371_journal.pone.0066551","plos one","2013-09-11T00:00:00Z","Cynthia A Beck; Danielle A Southern; Richard Saitz; Merril L Knudtson; William A Ghali","Department of Community Health Sciences, University of Calgary, Calgary, Alberta, Canada; Department of Psychiatry, University of Calgary, Calgary, Alberta, Canada; Clinical Addiction Research and Education Unit, Section of General Internal Medicine, Department of Medicine, Boston Medical Center and Boston University School of Medicine, Boston, Massachusetts, United States of America; Department of Epidemiology, Boston University School of Public Health, Boston, Massachusetts, United States of America; Faculty of Medicine, University of Calgary, Calgary, Alberta, Canada; Institute for Public Health (IPH), University of Calgary, Calgary, Alberta, Canada","Conceived and designed the experiments: CAB DAS RS MLK WAG. Performed the experiments: CAB DAS RS MLK WAG. Analyzed the data: DAS. Contributed reagents/materials/analysis tools: CAB DAS WAG. Wrote the paper: CAB DAS RS MLK WAG.","The authors have the following interests: APPROACH has been partly funded by the following industry sponsors: Merck Frosst Canada Inc., Roche Canada, Eli Lilly Canada Inc., Bristol-Myers Squibb, Philips Medical Systems Canada, Searle Pharmaceuticals, Boston Scientific Ltd and Cordis - A Johnson & Johnson Company. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2013","09","Cynthia A Beck","CAB",5,TRUE,5,5,1,5,TRUE,FALSE,FALSE,0,NA,FALSE
